IL-13-mediated immunological control of enterochromaffin cell hyperplasia and serotonin production in the gut

Mucosal Immunology

Volumn 6, Issue 1, 2013, Pages 146-155

  Manocha, M ^a   Shajib, M S ^a   Rahman, M M ^a   Wang, H ^a   Rengasamy, P ^a   Bogunovic, M ^b   Jordana, M ^a   Mayer, L ^b   Khan, W I ^a,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; MESSENGER RNA; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL HYPERPLASIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTEROCHROMAFFIN CELL; ENTEROCHROMAFFIN CELL HYPERPLASIA; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IMMUNOREGULATION; INTESTINE MUCOSA; MALE; MOUSE; NONHUMAN; PARASITE CLEARANCE; PARASITE LOAD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEROTONIN RELEASE; TRICHURIASIS; TRICHURIS MURIS; TRYPTOPHAN HYDROXYLASE 1 GENE; UPREGULATION; WILD TYPE; WORM EXPULSION;

EID: 84874025121     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.58     Document Type: Article

References (49)

1. Khan, W. I. & Ghia, J. E. Gut hormones: emerging role in immune activation and inflammation. Clin. Exp. Immunol. 161, 19-27 (2010).
2. Erspamer, V. Historical introduction: the Italian contribution to the discovery of 5-hydroxytryptamine (enteramine, serotonin). J. Hypertens. 4 (Suppl), S3 - S5 (1986).
3. Cetin, Y. et al. Enterochromaffin cells of the digestive system: cellular source of guanylin, a guanylate cyclase-activating peptide. Proc. Natl. Acad. Sci. USA 91, 2935-2939 (1994). (Pubitemid 24130149)
4. Braun, T. et al. Enterochromaffin cells of the human gut: sensors for spices and odorants. Gastroenterology 132, 1890-1901 (2007). (Pubitemid 46677937)
5. Camilleri, M. Serotonin in the gastrointestinal tract. Curr. Opin. Endocrinol. Diabetes. Obes. 16, 53-59 (2009).
6. Gershon, M. D. Serotonin: its role and receptors in enteric neurotransmission. Adv. Exp. Med. Biol. 294, 221-230 (1991).
7. Costedio, M. M., Hyman, N. & Mawe, G. M. Serotonin and its role in colonic function and in gastrointestinal disorders. Dis. Colon Rectum 50, 376-388 (2007). (Pubitemid 46394454)
8. Spiller, R. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol. Motil. 19 (Suppl 2), 25-31 (2007). (Pubitemid 47037963)
9. Coates, M. D. et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126, 1657-1664 (2004). (Pubitemid 38736329)
10. Magro, F. et al. Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig. Dis. Sci. 47, 216-224 (2002). (Pubitemid 34075041)
11. Miwa, J. et al. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion 63, 188-194 (2001). (Pubitemid 32429734)
12. Faure, C. et al. Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients. Gastroenterology 139, 249-258 (2010).
13. Coleman, N. S. et al. Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin. Gastroenterol. Hepatol. 4, 874-881 (2006). (Pubitemid 43994540)
14. Ataee, R. et al. Anti-mitogenic and apoptotic effects of 5-HT1B receptor antagonist on HT29 colorectal cancer cell line. J. Cancer. Res. Clin. Oncol. 136, 1461-1469 (2010).
15. Coogan, P. F., Strom, B. L. & Rosenberg, L. Antidepressant use and colorectal cancer risk. Pharmacoepidemiol. Drug Saf. 18, 1111-1114 (2009).
16. Costedio, M. M. et al. Serotonin signaling in diverticular disease. J. Gastrointest. Surg. 12, 1439-1445 (2008).
17. Moore, B. A., Sharkey, K. A. & Mantle, M. Role of 5-HT in cholera toxininduced mucin secretion in the rat small intestine. Am. J. Physiol. 270, G1001 - G1009 (1996).
18. Grondahl, M. L. et al. Secretory pathways in Salmonella Typhimuriuminduced fluid accumulation in the porcine small intestine. J. Med. Microbiol. 47, 151-157 (1998). (Pubitemid 28041259)
19. Kordasti, S. et al. Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea. Gut 53, 952-957 (2004). (Pubitemid 38824151)
20. Wheatcroft, J. et al. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol. Motil. 17, 863-870 (2005). (Pubitemid 41748282)
21. Wang, H. et al. CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection. Gut 56, 949-957 (2007). (Pubitemid 46999078)
22. Motomura, Y. et al. Enterochromaffin cell and 5-hydroxytryptamine responses to the same infectious agent differ in Th1 and Th2 dominant environments. Gut 57, 475-481 (2008). (Pubitemid 351442531)
23. Ghia, J. E. et al. Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology 137, 649-1660 (2009).
24. Li, N. et al. Serotonin activates dendritic cell function in the context of gut inflammation. Am. J. Pathol. 178, 662-671 (2011).
25. Chadwick, V. S. et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122, 1778-1783 (2002). (Pubitemid 34651421)
26. Collins, S. M., Piche, T. & Rampal, P. The putative role of inflammation in the irritable bowel syndrome. Gut 49, 743-745 (2001). (Pubitemid 33096023)
27. Spiller, R. & Garsed, K. Postinfectious irritable bowel syndrome. Gastroenterology 136, 1979-1988 (2009).
28. Yang, G. B. & Lackner, A. A. Proximity between 5-HT secreting enteroendocrine cells and lymphocytes in the gut mucosa of rhesus macaques (Macaca mulatta) is suggestive of a role for enterochromaffin cell 5-HT in mucosal immunity. J. Neuroimmunol. 146, 46-49 (2004). (Pubitemid 38032955)
29. Evers, B. M. et al. The human carcinoid cell line, BON. A model system for the study of carcinoid tumors. Ann. NY Acad. Sci. 733, 393-406 (1994).
30. Li, J. et al. Phorbol ester-mediated neurotensin secretion is dependent on the PKC-alpha and -delta isoforms. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G1197 - G1206 (2002). (Pubitemid 35192857)
31. Walther, D. J. et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299, 76 (2003). (Pubitemid 36042402)
32. Walther, D. J. & Bader, M. A unique central tryptophan hydroxylase isoform. Biochem. Pharmacol. 66, 1673-1680 (2003). (Pubitemid 37249312)
33. Vikman, S. et al. Gene expression in midgut carcinoid tumors: potential targets for immunotherapy. Acta. Oncol. 44, 32-40 (2005). (Pubitemid 40249126)
34. Qian, B. F., El-Salhy, M., Melgar, S., Hammarstrom, M. L. & Danielsson, A. Neuroendocrine changes in colon of mice with a disrupted IL-2 gene. Clin. Exp. Immunol. 120, 424-433 (2000). (Pubitemid 30365546)
35. Rubin, D. C. et al. Altered enteroendocrine cell expression in T cell receptor alpha chain knock-out mice. Microsc. Res. Tech. 51, 112-120 (2000).
36. O'Hara, J. R. et al. Consequences of Citrobacter rodentium infection on enteroendocrine cells and the enteric nervous system in the mouse colon. Cell. Microbiol. 8, 646-660 (2006). (Pubitemid 43372743)
37. Sun, X. et al. Circadian 5-HT production regulated by adrenergic signaling. Proc. Natl. Acad. Sci. USA 99, 4686-4691 (2002). (Pubitemid 34286045)
38. Sugden, D. Comparison of circadian expression of tryptophan hydroxylase isoform mRNAs in the rat pineal gland using real-time PCR. J. Neurochem. 86, 1308-1311 (2003). (Pubitemid 37022205)
39. Huang, Z. et al. Posttranslational regulation of TPH1 is responsible for the nightly surge of 5-HT output in the rat pineal gland. J. Pineal Res. 45, 506-514 (2008).
40. Silva, S. R. et al. The effect of PTEN on serotonin synthesis and secretion from the carcinoid cell line BON. Anticancer Res. 31, 1153-1160 (2011).
41. Kuhn, D. M., Arthur, R. Jr & States, J. C. Phosphorylation and activation of brain tryptophan hydroxylase: identification of serine-58 as a substrate site for protein kinase A. J. Neurochem. 68, 2220-2223 (1997). (Pubitemid 27176162)
42. Kumer, S. C. et al. Amino-terminal analysis of tryptophan hydroxylase: protein kinase phosphorylation occurs at serine-58. J. Neurochem. 69, 1738-1745 (1997). (Pubitemid 27406975)
43. Ishizuka, J. et al. Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells. J. Cell. Physiol. 150, 1-7 (1992).
44. Godfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J. & Van Kaer, L. NKT cells: what's in a name? Nat. Rev. Immunol. 4, 231-237 (2004). (Pubitemid 38339089)
45. McKenzie, G. J. et al. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr. Biol. 8, 339-342 (1998). (Pubitemid 28159120)
46. Wakelin, D. Studies on the immunity of albino mice to Trichuris muris. The stimulation of immunity by chemically abbreviated infections. Parasitology 59, 549-555 (1969).
47. Else, K. J. et al. The influence of genes mapping within the major histocompatibility complex on resistance to Trichuris muris infections in mice. Parasitology 101, 61-67 (1990). (Pubitemid 20297292)
48. Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034 (2002).
49. Smith, J. W. & Castro, G. A. Relation of peroxidase activity in gut mucosa to inflammation. Am. J. Physiol. 234, R72 - R79 (1978). (Pubitemid 9133199)